Clinical Trial Update: LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis [Phase 1, Phase 2]

View source ↗

Summary

Updates on the LEVANT I trial evaluating the Lutonix paclitaxel-coated balloon for preventing femoropopliteal restenosis; the Phase 1/2 study is completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Atherosclerosis
• Vascular Disease

Drugs mentioned

• Lutonix Paclitaxel-Coated Balloon (paclitaxel-coated balloon)

Snippet

Sponsor: C. R. Bard | Conditions: Atherosclerosis, Vascular Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-12-21